During the past decade, Valerius Medical Group conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 18 clinical trials were completed, i.e. on average, 112.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 12 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Valerius Medical Group" #1 sponsor was "Bristol-Myers Squibb" with 6 trials, followed by "Genentech, Inc." with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored and "Pfizer" with 3 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Valerius Medical Group" #1 collaborator was "OCT Clinical Trials" with 2 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Hexal AG" with 1 trials as a collaborator, "IQVIA Pvt. Ltd" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Valerius Medical Group" are "Rheumatoid Arthritis" (12 trials), "Systemic Lupus Erythematosus" (4 trials), "Arthritis, Rheumatoid" (3 trials), "Lupus Erythematosus, Systemic" (2 trials) and "Lupus Nephritis" (2 trials). Many other conditions were trialed in "Valerius Medical Group" in a lesser frequency.

Most popular intervention types in "Valerius Medical Group" are "Drug" (25 trials), "Other" (5 trials), "Biological" (3 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Abatacept" (3 trials), "Methotrexate" (3 trials), "Tocilizumab" (3 trials) and "GDC-0853" (2 trials). Other intervention names were less common.

The vast majority of trials in "Valerius Medical Group" are 28 trials for "All" genders.

Currently, there are NaN active trials in "Valerius Medical Group". 1 are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Valerius Medical Group, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Valerius Medical Group, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 1 trials that are defined as “Not Applicable".